Bobby Thomas

8.3k total citations · 2 hit papers
71 papers, 6.3k citations indexed

About

Bobby Thomas is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bobby Thomas has authored 71 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 31 papers in Neurology and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bobby Thomas's work include Parkinson's Disease Mechanisms and Treatments (27 papers), Genomics, phytochemicals, and oxidative stress (15 papers) and Nuclear Receptors and Signaling (10 papers). Bobby Thomas is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (27 papers), Genomics, phytochemicals, and oxidative stress (15 papers) and Nuclear Receptors and Signaling (10 papers). Bobby Thomas collaborates with scholars based in United States, Russia and India. Bobby Thomas's co-authors include M. Flint Beal, Ted M. Dawson, Valina L. Dawson, Rebecca Banerjee, Kochupurackal P. Mohanakumar, Navneet Ammal Kaidery, M. Flint Beal, Olga Pletniková, Juan C. Troncoso and Xiaojie Li and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Bobby Thomas

69 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

S -Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function

2004 636 citations Bobby Thomas, Olga Pletniková et al. profile →
Parkinson's disease

2007 579 citations Bobby Thomas, M. Flint Beal Human Molecular Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bobby Thomas United States	39	2.9k	2.9k	1.7k	1.5k	994	71	6.3k
Céline Perier Spain	33	2.6k 0.9×	3.5k 1.2×	2.2k 1.3×	1.8k 1.2×	950 1.0×	41	6.7k
Sonia Gandhi United Kingdom	41	3.0k 1.0×	3.2k 1.1×	1.8k 1.0×	1.9k 1.3×	1.1k 1.1×	86	6.8k
Alexander Panov United States	24	3.6k 1.2×	2.8k 1.0×	2.6k 1.5×	1.2k 0.8×	793 0.8×	51	6.7k
Eunsung Junn United States	33	3.0k 1.0×	2.3k 0.8×	1.6k 0.9×	1.0k 0.7×	776 0.8×	44	5.8k
Teresa G. Hastings United States	41	2.7k 0.9×	3.0k 1.0×	3.2k 1.9×	1.2k 0.8×	918 0.9×	54	7.2k
Senthilkumar S. Karuppagounder United States	32	1.8k 0.6×	1.8k 0.6×	1.1k 0.6×	1.0k 0.7×	643 0.6×	58	4.5k
Kunihiro Uryu United States	42	2.9k 1.0×	2.8k 1.0×	1.8k 1.1×	2.4k 1.6×	1.2k 1.2×	70	7.6k
Makoto Urushitani Japan	36	1.8k 0.6×	2.4k 0.8×	1.1k 0.6×	971 0.6×	928 0.9×	114	4.9k
Han Seok Ko United States	33	4.0k 1.4×	4.2k 1.4×	2.2k 1.3×	2.0k 1.3×	1.1k 1.1×	58	8.5k
Dagmar Galter Sweden	39	2.8k 0.9×	1.4k 0.5×	1.7k 1.0×	1.1k 0.7×	556 0.6×	76	5.6k

Countries citing papers authored by Bobby Thomas

Since Specialization

Citations

This map shows the geographic impact of Bobby Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobby Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobby Thomas more than expected).

Fields of papers citing papers by Bobby Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bobby Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobby Thomas. The network helps show where Bobby Thomas may publish in the future.

Co-authorship network of co-authors of Bobby Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Bobby Thomas. A scholar is included among the top collaborators of Bobby Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bobby Thomas. Bobby Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paul, Bindu D., et al.. (2025). Intersection of H2S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases. Neurotherapeutics. 22(6). e00627–e00627.

Kaidery, Navneet Ammal, Sudarshana M. Sharma, Irina G. Gazaryan, et al.. (2024). A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets. Frontiers in Pharmacology. 15. 1390798–1390798. 13 indexed citations

Cai, Lun, Ali S. Arbab, Tae Jin Lee, et al.. (2022). BACH1-Hemoxygenase-1 axis regulates cellular energetics and survival following sepsis. Free Radical Biology and Medicine. 188. 134–145. 19 indexed citations

Hushpulian, Dmitry M., Navneet Ammal Kaidery, Manuj Ahuja, et al.. (2021). Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue. Frontiers in Aging Neuroscience. 13. 673205–673205. 33 indexed citations

Cui, Xuezhi, Jing Zhao, Jing Wang, et al.. (2018). Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells. Experimental Eye Research. 178. 228–237. 30 indexed citations

Kaidery, Navneet Ammal & Bobby Thomas. (2018). Current perspective of mitochondrial biology in Parkinson's disease. Neurochemistry International. 117. 91–113. 70 indexed citations

Gazaryan, Irina G. & Bobby Thomas. (2016). The status of Nrf2-based therapeutics: current perspectives and future prospects. Neural Regeneration Research. 11(11). 1708–1708. 53 indexed citations

Naughton, Sean X., Heike Wulff, Vikrant Singh, et al.. (2015). Diisopropylfluorophosphate Impairs the Transport of Membrane-Bound Organelles in Rat Cortical Axons. Journal of Pharmacology and Experimental Therapeutics. 356(3). 645–655. 38 indexed citations

Wakade, Chandramohan, Raymond Chong, Eric L. Bradley, Bobby Thomas, & John C. Morgan. (2014). Upregulation of GPR109A in Parkinson’s Disease. PLoS ONE. 9(10). e109818–e109818. 70 indexed citations

10.

Thomas, Bobby, Allen S. Mandir, Neva West, et al.. (2012). Correction: Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation. PLoS ONE. 7(3). 3 indexed citations

11.

Andrés‐Mateos, Eva, Rebeca Mejı́as, Masayuki Sasaki, et al.. (2009). Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine). Journal of Neuroscience. 29(50). 15846–15850. 95 indexed citations

12.

Daher, João Paulo Lima, Mingyao Ying, Rebecca Banerjee, et al.. (2009). Conditional transgenic mice expressing C-terminally truncated human α-synuclein (αSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons. Molecular Neurodegeneration. 4(1). 34–34. 73 indexed citations

13.

Habib, Samy L., Eliezer Masliah, Bobby Thomas, et al.. (2008). Role of Tuberin in Neuronal Degeneration. Neurochemical Research. 33(6). 1113–1116. 10 indexed citations

14.

Thomas, Bobby, Rainer von Coelln, Allen S. Mandir, et al.. (2007). MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiology of Disease. 26(2). 312–322. 61 indexed citations

15.

Thomas, Bobby, Karuppagounder S. Saravanan, & Kochupurackal P. Mohanakumar. (2007). In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole. Neurochemistry International. 52(6). 990–1001. 46 indexed citations

16.

Hara, Makoto R., Bobby Thomas, Matthew B. Cascio, et al.. (2006). Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proceedings of the National Academy of Sciences. 103(10). 3887–3889. 191 indexed citations

17.

Coelln, Rainer von, Bobby Thomas, Shaida A. Andrabi, et al.. (2006). Inclusion Body Formation and Neurodegeneration Are Parkin Independent in a Mouse Model of α-Synucleinopathy. Journal of Neuroscience. 26(14). 3685–3696. 63 indexed citations

18.

Wang, Cheng, Han Seok Ko, Bobby Thomas, et al.. (2005). Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Human Molecular Genetics. 14(24). 3885–3897. 169 indexed citations

19.

Mohanakumar, Kochupurackal P., et al.. (2002). Nitric Oxide. Annals of the New York Academy of Sciences. 962(1). 389–401. 83 indexed citations

20.

Sivadasan, M., et al.. (2001). Lagenandra keralensis (Araceae), a remarkable new species from India. Zhōngyāng yánjiūyuàn zhíwùxué huikān/Zhōngyāng yánjiūyuàn zhíwùxué huikān. 42(2). 153–157. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact